72 related articles for article (PubMed ID: 3337531)
1. [Influence of a fosfomycin combination on the anti-tumor effect of CDDP].
Sagara N; Nakano K; Aizawa M; Hara S; Inufusa H; Mori N; Kurooka K; Haeno Y; Yasutomi M
Gan To Kagaku Ryoho; 1988 Jan; 15(1):97-100. PubMed ID: 3337531
[TBL] [Abstract][Full Text] [Related]
2. [Prophylactic effect of fosfomycin on CDDP nephrotoxicity].
Yogi S; Ikeuchi T; Kai Y
Hinyokika Kiyo; 1989 Apr; 35(4):615-21. PubMed ID: 2735267
[TBL] [Abstract][Full Text] [Related]
3. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
Saito M; Masaki T; Kato H; Numasaka K
Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
[TBL] [Abstract][Full Text] [Related]
4. [Urinary NAG and gamma-GTP activities as indicators of CDDP renal toxicity: effect of fosfomycin on CDDP renal toxicity].
Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
Hinyokika Kiyo; 1986 Sep; 32(9):1237-45. PubMed ID: 2880486
[TBL] [Abstract][Full Text] [Related]
5. [Experimental chemotherapy of human testicular carcinoma transplanted in nude mice].
Yanagisawa M; Machida T; Miki M; Tanino M; Akasaka Y; Higashi Y; Kondo N
Gan To Kagaku Ryoho; 1983 May; 10(5):1299-307. PubMed ID: 6191680
[TBL] [Abstract][Full Text] [Related]
6. [Influence of methylprednisolone on antitumor effect of cis-diamminedichloroplatinum (II)].
Lee K; Kubota T; Sawamara M; Kadowaki K; Kawamura E; Egawa S; Ishibashi A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1444-9. PubMed ID: 6540069
[TBL] [Abstract][Full Text] [Related]
7. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
Fujita F; Fujita M; Sakamoto Y; Taguchi T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):215-21. PubMed ID: 8382036
[TBL] [Abstract][Full Text] [Related]
9. An experimental study on the therapeutic effect of consecutive low-dose cisplatin with caffeine in sarcoma-bearing mice.
Takeda A; Tsuchiya H; Tajino T; Kikuchi S
Anticancer Res; 2005; 25(4):2777-84. PubMed ID: 16080526
[TBL] [Abstract][Full Text] [Related]
10. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
13. cis-Diamminedichloroplatinum (CDDP)-fosfomycin (FOM) combination in lung cancer patients with respect to the peripheral T lymphocyte subsets.
Kumano N; Koinumaru S; Oizumi K; Konno K
Tohoku J Exp Med; 1986 Mar; 148(3):333-4. PubMed ID: 3518153
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of combination chemotherapy with 5-FU and CDDP for human gastric carcinoma transplanted into nude mice].
Yamada T; Tanase M; Watanabe A; Sawada H; Yamada Y; Shino Y; Yamashita J; Matsuda M; Nakano H
Gan To Kagaku Ryoho; 1997 Jan; 24(1):43-7. PubMed ID: 9020944
[TBL] [Abstract][Full Text] [Related]
15. [Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer].
Uchida J; Satake H; Saito H; Nakano K; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1001-8. PubMed ID: 8210249
[TBL] [Abstract][Full Text] [Related]
16. Verapamil enhancement of antitumor effect of cis-diamminedichloroplatinum(II) in nude mouse-grown human neuroblastoma.
Ikeda H; Nakano G; Nagashima K; Sakamoto K; Harasawa N; Kitamura T; Nakamura T; Nagamachi Y
Cancer Res; 1987 Jan; 47(1):231-4. PubMed ID: 3791210
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cisplatin (CDDP) against peritonitis carcinomatosa in nude mice inoculated intraperitoneally with human gastric cancer].
Takao S; Nomura H; Aikou T; Maenohara S; Saihara T; Kajisa T; Nishi M
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1638-43. PubMed ID: 3896155
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum.
Koenuma M; Kasai H; Uchida N; Wada T; Hattori M; Oguma T; Totani T; Inaba M
Anticancer Res; 1995; 15(2):417-21. PubMed ID: 7763015
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of CDDP and VP-16 against human bladder cancers.
Gotoh A; Mizuno Y; Okada H; Arakawa S; Kitazawa S; Maeda S; Kamidono S
In Vivo; 1995; 9(3):263-7. PubMed ID: 8562894
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of CDDP and caffeine against human gastric cell line in vivo.
Takahashi M; Yanoma S; Yamamoto Y; Rino Y; Amano T; Imada T
Anticancer Res; 1998; 18(6A):4399-401. PubMed ID: 9891499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
